426 related articles for article (PubMed ID: 23177488)
1. Detection and prevention of cardiac complications of cancer chemotherapy.
Monsuez JJ
Arch Cardiovasc Dis; 2012 Nov; 105(11):593-604. PubMed ID: 23177488
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular toxicities of cancer chemotherapy.
Bonita R; Pradhan R
Semin Oncol; 2013 Apr; 40(2):156-67. PubMed ID: 23540741
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention].
Nelson-Veniard M; Thambo JB
Bull Cancer; 2015; 102(7-8):622-6. PubMed ID: 25935231
[TBL] [Abstract][Full Text] [Related]
4. Role of biomarkers in chemotherapy-induced cardiotoxicity.
Cardinale D; Sandri MT
Prog Cardiovasc Dis; 2010; 53(2):121-9. PubMed ID: 20728699
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.
Bryant J; Picot J; Levitt G; Sullivan I; Baxter L; Clegg A
Health Technol Assess; 2007 Jul; 11(27):iii, ix-x, 1-84. PubMed ID: 17610809
[TBL] [Abstract][Full Text] [Related]
6. Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy.
Wiseman LR; Spencer CM
Drugs; 1998 Sep; 56(3):385-403. PubMed ID: 9777314
[TBL] [Abstract][Full Text] [Related]
7. Cardiac testing to manage cardiovascular risk in cancer patients.
Davis M; Witteles RM
Semin Oncol; 2013 Apr; 40(2):147-55. PubMed ID: 23540740
[TBL] [Abstract][Full Text] [Related]
8. Cardiac side-effects of cancer chemotherapy.
Monsuez JJ; Charniot JC; Vignat N; Artigou JY
Int J Cardiol; 2010 Sep; 144(1):3-15. PubMed ID: 20399520
[TBL] [Abstract][Full Text] [Related]
9. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
10. Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies.
Wouters KA; Kremer LC; Miller TL; Herman EH; Lipshultz SE
Br J Haematol; 2005 Dec; 131(5):561-78. PubMed ID: 16351632
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
Jensen BV
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
[TBL] [Abstract][Full Text] [Related]
12. Strategies for reduction of anthracycline cardiac toxicity.
Speyer J; Wasserheit C
Semin Oncol; 1998 Oct; 25(5):525-37. PubMed ID: 9783592
[TBL] [Abstract][Full Text] [Related]
13. Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity.
Germanakis I; Anagnostatou N; Kalmanti M
Pediatr Blood Cancer; 2008 Sep; 51(3):327-33. PubMed ID: 18523992
[TBL] [Abstract][Full Text] [Related]
14. Using cardiac biomarkers and treating cardiotoxicity in cancer.
Colombo A; Cardinale D
Future Cardiol; 2013 Jan; 9(1):105-18. PubMed ID: 23259478
[TBL] [Abstract][Full Text] [Related]
15. European trials with dexrazoxane in amelioration of doxorubicin and epirubicin-induced cardiotoxicity.
Lopez M; Vici P
Semin Oncol; 1998 Aug; 25(4 Suppl 10):55-60. PubMed ID: 9768825
[TBL] [Abstract][Full Text] [Related]
16. Anthracycline-related cardiotoxicity in childhood cancer survivors.
Lipshultz SE; Karnik R; Sambatakos P; Franco VI; Ross SW; Miller TL
Curr Opin Cardiol; 2014 Jan; 29(1):103-12. PubMed ID: 24284979
[TBL] [Abstract][Full Text] [Related]
17. [Cardiotoxicity of antracycline treatment in the light of new biochemical diagnostic options].
Urbanová D; Mladosievicová B
Vnitr Lek; 2007 Jun; 53(6):669-77. PubMed ID: 17702127
[TBL] [Abstract][Full Text] [Related]
18. Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents.
Chen C; Heusch A; Donner B; Janssen G; Göbel U; Schmidt KG
Klin Padiatr; 2009; 221(3):162-6. PubMed ID: 19437364
[TBL] [Abstract][Full Text] [Related]
19. The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature.
Mavinkurve-Groothuis AM; Kapusta L; Nir A; Groot-Loonen J
Pediatr Hematol Oncol; 2008 Sep; 25(7):655-64. PubMed ID: 18850478
[TBL] [Abstract][Full Text] [Related]
20. Cancer drugs and the heart: importance and management.
Suter TM; Ewer MS
Eur Heart J; 2013 Apr; 34(15):1102-11. PubMed ID: 22789916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]